View in EDS PDF Full Text

Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.

Saved in:
Bibliographic Details
Title: Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
Authors: Xie X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. xuxie@UTMB.edu., Muruato AE; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Zhang X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA., Lokugamage KG; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Fontes-Garfias CR; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA., Zou J; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA., Liu J; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Ren P; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA., Balakrishnan M; Gilead Sciences, Inc., Foster City, CA, USA., Cihlar T; Gilead Sciences, Inc., Foster City, CA, USA., Tseng CK; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Makino S; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Menachery VD; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA., Bilello JP; Gilead Sciences, Inc., Foster City, CA, USA. john.bilello@gilead.com., Shi PY; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.; Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.
Source: Nature communications [Nat Commun] 2021 Jun 21; Vol. 12 (1), pp. 3984. Date of Electronic Publication: 2021 Jun 21.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34155200
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Xie+X%22">Xie X</searchLink>; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. xuxie@UTMB.edu.<br /><searchLink fieldCode="AU" term="%22Muruato+AE%22">Muruato AE</searchLink>; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lokugamage+KG%22">Lokugamage KG</searchLink>; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Fontes-Garfias+CR%22">Fontes-Garfias CR</searchLink>; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Zou+J%22">Zou J</searchLink>; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ren+P%22">Ren P</searchLink>; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Balakrishnan+M%22">Balakrishnan M</searchLink>; Gilead Sciences, Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cihlar+T%22">Cihlar T</searchLink>; Gilead Sciences, Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tseng+CK%22">Tseng CK</searchLink>; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Makino+S%22">Makino S</searchLink>; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Menachery+VD%22">Menachery VD</searchLink>; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bilello+JP%22">Bilello JP</searchLink>; Gilead Sciences, Inc., Foster City, CA, USA. john.bilello@gilead.com.<br /><searchLink fieldCode="AU" term="%22Shi+PY%22">Shi PY</searchLink>; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.; Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2021 Jun 21; Vol. 12 (1), pp. 3984. <i>Date of Electronic Publication: </i>2021 Jun 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34155200
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-021-24300-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3984
    Titles:
      – TitleFull: Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xie X
      – PersonEntity:
          Name:
            NameFull: Muruato AE
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Lokugamage KG
      – PersonEntity:
          Name:
            NameFull: Fontes-Garfias CR
      – PersonEntity:
          Name:
            NameFull: Zou J
      – PersonEntity:
          Name:
            NameFull: Liu J
      – PersonEntity:
          Name:
            NameFull: Ren P
      – PersonEntity:
          Name:
            NameFull: Balakrishnan M
      – PersonEntity:
          Name:
            NameFull: Cihlar T
      – PersonEntity:
          Name:
            NameFull: Tseng CK
      – PersonEntity:
          Name:
            NameFull: Makino S
      – PersonEntity:
          Name:
            NameFull: Menachery VD
      – PersonEntity:
          Name:
            NameFull: Bilello JP
      – PersonEntity:
          Name:
            NameFull: Shi PY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 06
              Text: 2021 Jun 21
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1